It is time to buy VRS.v - Currently priced in the low .60's. Down in half in approximately two weeks. They had clinical trials where 100% effectiveness was found. Out of a trial group of over 270 patients, 33 patients had cancerous indicators. VRS product detected 33 out of 33 cases. They are about to come out with additional results that will propel this stock into the multiple dollars. Please do your own research, and make sure you listen to the audio clip I will post below. This is a no-brainer at these prices.